Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer 01/23/2014 OBSERVATIONAL unchanged 4,598.85 0 TAILORx Tissue Bank 01/31/2014 OBSERVATIONAL unchanged 4,590.85 0 Discovering the Antecedents of Rheumatoid Arthritis Flare 01/31/2014 OBSERVATIONAL unchanged 4,590.85 0 A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread 02/06/2014 INTERVENTIONAL unchanged 4,584.85 0 Mother and Infant Home Visiting Program Evaluation 02/24/2014 INTERVENTIONAL unchanged 4,566.85 0 The Role of Lifestyle Factors in Breast Cancer-Related Outcomes 03/06/2014 INTERVENTIONAL unchanged 4,556.85 0 Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer 03/17/2014 INTERVENTIONAL unchanged 4,545.85 0 Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry 04/01/2014 OBSERVATIONAL unchanged 4,530.85 0 Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer 04/02/2014 INTERVENTIONAL unchanged 4,529.85 0 Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project 04/03/2014 OBSERVATIONAL unchanged 4,528.85 0 A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer 04/08/2014 INTERVENTIONAL unchanged 4,523.85 0 Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History 04/24/2014 OBSERVATIONAL unchanged 4,507.85 0 HOT: HIPEC in Ovarian Cancer as Initial Treatment 04/28/2014 INTERVENTIONAL unchanged 4,503.85 0 The Expecting Study 04/29/2014 INTERVENTIONAL unchanged 4,502.85 0 European Active Surveillance Study of LCS12 05/26/2014 OBSERVATIONAL unchanged 4,475.85 0 Effectiveness of Cervical Screening in HPV Vaccinated Women 05/29/2014 INTERVENTIONAL unchanged 4,472.85 0 Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer 06/12/2014 INTERVENTIONAL unchanged 4,458.85 0 Sentinel Node Vs Observation After Axillary Ultra-souND 06/19/2014 INTERVENTIONAL unchanged 4,451.85 0 Incidence of Difficult Airway and Difficult Neuraxial Placement in Obstetric Patients 07/17/2014 OBSERVATIONAL unchanged 4,423.85 0 Functional Snack Foods With Safflower Oil and Soy in Postmenopausal Women Having Metabolic Syndrome 07/24/2014 INTERVENTIONAL unchanged 4,416.85 0 Pazopanib Vs. Pazopanib Plus Gemcitabine 07/30/2014 INTERVENTIONAL unchanged 4,410.85 0 Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy 07/30/2014 INTERVENTIONAL unchanged 4,410.85 0 mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian 08/05/2014 INTERVENTIONAL unchanged 4,404.85 0 Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients 08/21/2014 INTERVENTIONAL unchanged 4,388.85 0 Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer 08/27/2014 INTERVENTIONAL unchanged 4,382.85 0 Vaginal Flora for Treatment of Bacterial Vaginosis 09/10/2014 INTERVENTIONAL unchanged 4,368.85 0 A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers 09/12/2014 INTERVENTIONAL unchanged 4,366.85 0 Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions 09/12/2014 OBSERVATIONAL unchanged 4,366.85 0 Energy Balance and Breast Cancer Aspects-II 09/16/2014 INTERVENTIONAL unchanged 4,362.85 0 A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer 09/23/2014 INTERVENTIONAL unchanged 4,355.85 0 Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer 10/06/2014 INTERVENTIONAL unchanged 4,342.85 0 Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET 10/10/2014 INTERVENTIONAL unchanged 4,338.85 0 Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy 10/22/2014 INTERVENTIONAL unchanged 4,326.85 0 Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial 10/28/2014 INTERVENTIONAL unchanged 4,320.85 0 Comparison of Regimens MPIB, CIPCEA, PCEA 10/30/2014 INTERVENTIONAL unchanged 4,318.85 0 Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy: 11/03/2014 OBSERVATIONAL unchanged 4,314.85 0 [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer 11/06/2014 INTERVENTIONAL unchanged 4,311.85 0 Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer 11/06/2014 INTERVENTIONAL unchanged 4,311.85 0 DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics 11/11/2014 OBSERVATIONAL unchanged 4,306.85 0 TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer 11/14/2014 INTERVENTIONAL unchanged 4,303.85 0 Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer 11/14/2014 INTERVENTIONAL unchanged 4,303.85 0 Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention 11/20/2014 INTERVENTIONAL unchanged 4,297.85 0 Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant 11/21/2014 INTERVENTIONAL unchanged 4,296.85 0 MRI Assessment of Placental Health 11/21/2014 OBSERVATIONAL unchanged 4,296.85 0 Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease 11/26/2014 INTERVENTIONAL unchanged 4,291.85 0 MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study 11/26/2014 OBSERVATIONAL unchanged 4,291.85 0 Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI 12/03/2014 OBSERVATIONAL unchanged 4,284.85 0 Sickle Cell Hemoglobinopathies and Bone Health 12/03/2014 OBSERVATIONAL unchanged 4,284.85 0 Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer 12/04/2014 INTERVENTIONAL unchanged 4,283.85 0 Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer 12/09/2014 INTERVENTIONAL unchanged 4,278.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology